Table 2 The characteristics of patients with prostate cancer from the clinic database with values of PSA before and after treatment, number of treatments, duration of treatments and percentage of improvement

Prostate

Gleason score - 6-9

1507

46

531

98

96.9

Prostate

Grade II-III; Stage B2

116

3.7

302

7

96.8

Prostate

ND

788

21.1

112

15

97.3

Prostate

Gleason score 2.5

54

12.3

343

32

77.2

Prostate

ND

35.8

1

89

10

97.2

Prostate

Gleason 7

48.8

5.8

4863

18

88.1

Prostate

Gleason score 6

44

2.7

161

20

93.9

Prostate

Gleason score 9

5.1

71.2

143

33

−1296.1

Prostate

ND

65

184

588

13

−183.1

Prostate

Gleason score 4

26

5.5

146

5

78.8

Prostate

Gleason score 4

63

0.5

112

7

99.2

Prostate

Gleason score 5

20

2.3

214

6

88.5

Prostate

ND

153

87

247

4

43.1

Prostate

ND

7.3

2.3

136

8

68.5

Prostate

Gleason score 6

11

8

887

42

27.3

Prostate, metastatic

ND

51.3

21

500

32

59.1

Prostate, metastatic

ND

21

37.1

139

52

−76.7

Prostate

Gleason score 8

8

0.1

481

28

98.8

Prostate

ND

14.6

36.2

1652

81

−147.9

Prostate

Gleason score 6

11

29

1000

11

−163.6

Prostate, metastatic

ND

28.6

86.9

89

24

−203.8

Prostate

Gleason score 6-8

48.8

1.2

121

15

97.5

Prostate

Gleason score 6

65.2

13.8

45

4

78.8

Prostate

Gleason score 6-8

106

86.5

310

11

18.4

Prostate, metastatic

Stage II

500

54.3

542

77

89.1

Prostate

Gleason score 6.5, stage II

10.6

7.5

643

27

29.2